DAVID
GARCIA AZORIN
PROFESOR ASOCIADO
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (9)
2024
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
2023
-
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Cephalalgia : an international journal of headache, Vol. 43, Núm. 1
2022
-
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709
-
Headache education and management in Cameroon: a healthcare provider study
Acta Neurologica Belgica, Vol. 122, Núm. 1, pp. 75-81
2021
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092
-
Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091
-
Identifying areas for improvement in epilepsy management in developing countries: An experience of neurocooperation in Cameroon
Neurologia, Vol. 36, Núm. 1, pp. 29-33
2019
-
Neurología y cooperación: ¿Utopía o realidad? Experiencia de un proyecto pionero de neurocooperación en África
Kranion, Vol. 14, Núm. 2, pp. 67-72